Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis

Fig. 6

HUCMSC treatment liver fibrosis mice decreased the proportion of CD4+ IFN-γ+ T-cell (Th1) subset, compared with liver fibrosis group. UC5 HUCMSC treatment caused a lower CD4+ Th1 subset differentiation of splenocytes, compared with UC11 and UC12 HUCMSCs. UC12 HUCMSC treatment significantly promoted the Tregs differentiation of spenocytes, compared with UC5 and UC11 HUCMSC treatments (*p < 0.05, **p < 0.01, ***p < 0.001)

Back to article page